PMC7441452_01
Peripheral blood smear showing microcytic, slightly hypochromic anemia with anisocytosis and polychromasia, thrombocytopenia, and slight leukocytosis. Teardrop cells, reticulocytes, and small spherocytes are present. No overt schistocytes, fragmentation of red blood cells, overt dysplasia, or presence of blasts noted.
CRIOG2020-8862545.001.jpg
PMC7441452_01_CRIOG2020-8862545.001.jpg
fig1
Peripheral blood smear (Figure 1) revealed microcytic anemia with anisocytosis, polychromasia, and thrombocytopenia.
Platelet and hemoglobin values over time. Times of therapy noted by colored arrows. Initial course of steroids with good response, however subsequent decline in platelet count, requiring further treatment with additional steroids, IVIG, and rituximab. Abbreviations: IVIG: intravenous immunoglobulin.
CRIOG2020-8862545.002.jpg
PMC7441452_01_CRIOG2020-8862545.002.jpg
fig2
She was treated with oral dexamethasone, 40 mg daily for 4 days, with a subsequent rise in platelets to 55 K/muL (Figure 2).
Computed tomography of the chest demonstrating diffuse ground-glass opacities (a) throughout both lungs, which can be seen with COVID-19 pneumonia. Acute pulmonary emboli (b) identified in segmental branches of lingula and left inferior lobar pulmonary artery extending into segmental branches of left lower lobe, with filling defect noted by red arrow.
CRIOG2020-8862545.003.jpg
PMC7441452_01_CRIOG2020-8862545.003.jpg
fig3
Imaging revealed ground-glass opacities and an acute pulmonary embolism (Figure 3).